Gain Therapeutics (GANX) Insider Trading & Ownership → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free GANX Stock Alerts $2.68 -0.22 (-7.59%) (As of 04:27 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Gain Therapeutics (NASDAQ:GANX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage11.00%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$115,800.00Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$506.76 Get GANX Insider Trade Alerts Want to know when executives and insiders are buying or selling Gain Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GANX Insider Buying and Selling by Quarter Ad Unstoppable ProsperityRSVP: Charles Payne’s Cash Flow WorkshopAre you ready to find untapped value in the stocks you already own… Without selling a single share… Then you need to know these Cash Flow Trade Strategies.Register For Free Now! Gain Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/28/2024Jeffrey Scott RileyDirectorBuy30,000$3.86$115,800.00 12/21/2023Matthias AlderCEOSell206$2.46$506.76 (Data available from 1/1/2013 forward) GANX Insider Trading Activity - Frequently Asked Questions Who is on Gain Therapeutics's Insider Roster? The list of insiders at Gain Therapeutics includes Eric I Richman, Jeffrey Scott Riley, and Matthias Alder. Learn more on insiders at GANX. What percentage of Gain Therapeutics stock is owned by insiders? 11.00% of Gain Therapeutics stock is owned by insiders. Learn more on GANX's insider holdings. Which Gain Therapeutics insiders have been buying company stock? The following insiders have purchased GANX shares in the last 24 months: Eric I Richman ($17,243.56), and Jeffrey Scott Riley ($115,800.00). How much insider buying is happening at Gain Therapeutics? Insiders have purchased a total of 36,482 GANX shares in the last 24 months for a total of $133,043.56 bought. Which Gain Therapeutics insiders have been selling company stock? The following insider sold GANX shares in the last 24 months: Matthias Alder ($506.76). How much insider selling is happening at Gain Therapeutics? Insiders have sold a total of 206 Gain Therapeutics shares in the last 24 months for a total of $506.76 sold. More Insider Trading Tools from MarketBeat Related Companies: Aadi Bioscience Insider Selling Nabriva Therapeutics Insider Selling Checkpoint Therapeutics Insider Selling Equillium Insider Selling Bolt Biotherapeutics Insider Selling Immuneering Insider Selling HCW Biologics Insider Selling Eagle Pharmaceuticals Insider Selling Cara Therapeutics Insider Selling Lantern Pharma Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:GANX) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyAI “wealth window” is closing June 25thParadigm PressGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gain Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
